<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02263404</url>
  </required_header>
  <id_info>
    <org_study_id>PINS-004</org_study_id>
    <nct_id>NCT02263404</nct_id>
  </id_info>
  <brief_title>PINS Stimulator System to Treat Severe Anorexia Nervosa</brief_title>
  <official_title>PINS Stimulator System to Treat Severe Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Pins Medical Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Pins Medical Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia Nervosa (AN) has the highest mortality of any psychiatric disorder and a paucity of&#xD;
      effective treatments. AN becomes intractable in around 20%, resulting in huge individual and&#xD;
      healthcare costs. The study will help patients with severe AN using DBS. Individuals with&#xD;
      severe intractable AN will be eligible to take part in the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Eating Disorder Related Preoccupations and Rituals</measure>
    <time_frame>Change from baseline in Eating Disorder Related Preoccupations and Rituals scores at 3 months, 6 months and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hamilton Depression Rating Scale</measure>
    <time_frame>Change from baseline at 3 months, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Survey Short Form (SF-36)</measure>
    <time_frame>Change from baseline at 3 months, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DBS Implant and stimulation Intervention: Device: Deep Brain Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>DBS Implant Stimulation</description>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <other_name>Rechargeable Neurostimulator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Female or male patients aged 20-60 years.&#xD;
&#xD;
          2. Diagnosis of anorexia nervosa, restricting or binge-purging subtype, as defi ned in&#xD;
             the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR).&#xD;
&#xD;
          3. Chronicity or treatment resistance shown by some or all of:&#xD;
&#xD;
               -  A pattern of 3 years' duration of relentless unresponsiveness to repeated&#xD;
                  voluntary hospital admissions, characterised by failure to complete treatment or&#xD;
                  immediate weight relapse after treatment.&#xD;
&#xD;
               -  A pattern of increasing medical instability, accompanied by refusal to&#xD;
                  participate in or a pattern of poor response to intensive expert treatment and&#xD;
                  increasing medical acuity, lasting at least 2 years and including at least two&#xD;
                  episodes of involuntary feeding.&#xD;
&#xD;
               -  A pattern of chronic stable anorexia nervosa that has lasted at least 10 years.&#xD;
&#xD;
               -  Able to provide informed consent.&#xD;
&#xD;
          4. Able to comply with all testing, follow-ups, and study appointments and protocols.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Person with consciousness disorder on opioid abstinence, seriously aggressive, heavily&#xD;
             dehydrated and intending to commit suicide.&#xD;
&#xD;
          2. Patients with serious liver and kidney dysfunction, pulmonary decompensation, or&#xD;
             complicated with serious damage in other systems.&#xD;
&#xD;
          3. Patients with serious infectious disease.&#xD;
&#xD;
          4. Patients with history of serious neurological or psychiatrical diseases.&#xD;
&#xD;
          5. Person with history of HIV infection or serious malnutrition.&#xD;
&#xD;
          6. Dependent upon and addicted to multiple drugs.&#xD;
&#xD;
          7. Any contraindication to MRI or PET scanning.&#xD;
&#xD;
          8. Body-mass index less than 13.&#xD;
&#xD;
          9. Attended some other trials within one year.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Luming, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Tsinghua University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jia Fumin, PhD</last_name>
    <phone>+86 010-59361265</phone>
    <email>pins_medical@163.com</email>
  </overall_contact>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>September 27, 2014</study_first_submitted>
  <study_first_submitted_qc>October 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2014</study_first_posted>
  <last_update_submitted>October 13, 2016</last_update_submitted>
  <last_update_submitted_qc>October 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

